跳至主要内容
临床试验/NL-OMON56395
NL-OMON56395招募中不适用

Fetal Cells from the maternal circulation for Noninvasive Prenatal Diagnosis Study (FC-NIPD Study), part I - NIPD-study

Mitsui Chemicals0 个研究点目标入组 250 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • In order to be eligible to participate in this study, a subject must meet all
  • of the following criteria:
  • Pregnant of viable singleton or twin pregnancy at the time of the blood draw
  • (confirmed and dated by ultrasound);
  • At least 18 years of age and able to provide informed consent;
  • Pregnancy at the time of blood draw of at least a confirmed gestational age
  • of 9 weeks 0 days.

排除标准

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • Subject is pregnant with more than two fetuses or has had sonographic
  • evidence of three or more gestational sacs at any time during pregnancy;
  • Subject has a fetal demise (including natural or elective reduction)
  • identified prior to consent;
  • Subject has a history of malignancy treated with chemotherapy and/or major
  • surgery, or bone marrow transplant.
  • Subject is positive for any of the infectious tests on hepatitis B, hepatitis
  • C, syphilis, HIV or HTLV-1.
  • Subject has an obvious ectopic gestation.
  • Subject is judged as inappropriate by a research rector.

研究者

发起方
Mitsui Chemicals

相似试验